about
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for ...
Read More
5.31
-0.30
(-5.35%)
27,138
XNAS Volume
XNAS 15 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Inventiva - ADR is on 25 Sep 2025 for the purpose of Inventiva SA Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Inventiva ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..